Global Oligonucleotide Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 14-Sep-2018
No. of pages: 120

Oligonucleotide therapeutics are different from conventional medicine as they can inhibit the expression of certain genes. This has given rise to innovative new oligonucleotides that can target specific genes and treat chronic diseases. The development of oligonucleotide therapeutics is done through chemically modified artificial nucleic acids. The artificial oligonucleotides are being developed which has improved in vivo stability and enhanced affinity to target mRNA.

Scope of the Report:

This report studies the Oligonucleotide Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oligonucleotide Therapeutics market by product type and applications/end industries.

Asia-Pacific is the fastest growing region as several oligonucleotide therapeutics manufacturers are looking forward to establishing manufacturing facilities in this region. Moreover, research undertaking and funding in the synthesis of oligonucleotides are expected to add on to the increasing demand.

The global Oligonucleotide Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oligonucleotide Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

-Pfizer

-Merck

-Biogen

-PCI Biotech

-SomaGenics

-ContraVir

-Alnylam

-Regulus Therapeutics

-Ionis Pharmaceuticals

-Gilead

-Santaris Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

-Antisense

-Ribozymes

-Aptamers

-miRNA

-CpG/Immunostimulatory

-RNAi

-Others

Market Segment by Applications, can be divided into

-Infectious Diseases

-Oncology

-Neurodegenerative Disorders

-Cardiovascular Diseases

-Kidney Diseases

-Others

Global Oligonucleotide Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Oligonucleotide Therapeutics Market Overview
1.1 Product Overview and Scope of Oligonucleotide Therapeutics
1.2 Classification of Oligonucleotide Therapeutics by Types
1.2.1 Global Oligonucleotide Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Oligonucleotide Therapeutics Revenue Market Share by Types in 2017
1.2.3 Antisense
1.2.4 Ribozymes
1.2.5 Aptamers
1.2.6 miRNA
1.2.7 CpG/Immunostimulatory
1.2.8 RNAi
1.2.9 Others
1.3 Global Oligonucleotide Therapeutics Market by Application
1.3.1 Global Oligonucleotide Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Neurodegenerative Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Kidney Diseases
1.3.7 Others
1.4 Global Oligonucleotide Therapeutics Market by Regions
1.4.1 Global Oligonucleotide Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Oligonucleotide Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oligonucleotide Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oligonucleotide Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Oligonucleotide Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oligonucleotide Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Oligonucleotide Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Oligonucleotide Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Oligonucleotide Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen
2.3.1 Business Overview
2.3.2 Oligonucleotide Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 PCI Biotech
2.4.1 Business Overview
2.4.2 Oligonucleotide Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 PCI Biotech Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 SomaGenics
2.5.1 Business Overview
2.5.2 Oligonucleotide Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 SomaGenics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 ContraVir
2.6.1 Business Overview
2.6.2 Oligonucleotide Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ContraVir Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Alnylam
2.7.1 Business Overview
2.7.2 Oligonucleotide Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alnylam Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Regulus Therapeutics
2.8.1 Business Overview
2.8.2 Oligonucleotide Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Regulus Therapeutics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ionis Pharmaceuticals
2.9.1 Business Overview
2.9.2 Oligonucleotide Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Gilead
2.10.1 Business Overview
2.10.2 Oligonucleotide Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gilead Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Santaris Pharma
2.11.1 Business Overview
2.11.2 Oligonucleotide Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Santaris Pharma Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oligonucleotide Therapeutics Market Competition, by Players
3.1 Global Oligonucleotide Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Oligonucleotide Therapeutics Players Market Share
3.2.2 Top 10 Oligonucleotide Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Oligonucleotide Therapeutics Market Size by Regions
4.1 Global Oligonucleotide Therapeutics Revenue and Market Share by Regions
4.2 North America Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Oligonucleotide Therapeutics Revenue by Countries
5.1 North America Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
5.2 USA Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Oligonucleotide Therapeutics Revenue by Countries
6.1 Europe Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Oligonucleotide Therapeutics Revenue by Countries
7.1 Asia-Pacific Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
7.2 China Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Oligonucleotide Therapeutics Revenue by Countries
8.1 South America Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Oligonucleotide Therapeutics by Countries
9.1 Middle East and Africa Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Oligonucleotide Therapeutics Market Segment by Type
10.1 Global Oligonucleotide Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Oligonucleotide Therapeutics Market Forecast by Type (2018-2023)
10.3 Antisense Revenue Growth Rate (2013-2023)
10.4 Ribozymes Revenue Growth Rate (2013-2023)
10.5 Aptamers Revenue Growth Rate (2013-2023)
10.6 miRNA Revenue Growth Rate (2013-2023)
10.7 CpG/Immunostimulatory Revenue Growth Rate (2013-2023)
10.8 RNAi Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)
11 Global Oligonucleotide Therapeutics Market Segment by Application
11.1 Global Oligonucleotide Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Oligonucleotide Therapeutics Market Forecast by Application (2018-2023)
11.3 Infectious Diseases Revenue Growth (2013-2018)
11.4 Oncology Revenue Growth (2013-2018)
11.5 Neurodegenerative Disorders Revenue Growth (2013-2018)
11.6 Cardiovascular Diseases Revenue Growth (2013-2018)
11.7 Kidney Diseases Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Oligonucleotide Therapeutics Market Size Forecast (2018-2023)
12.1 Global Oligonucleotide Therapeutics Market Size Forecast (2018-2023)
12.2 Global Oligonucleotide Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Oligonucleotide Therapeutics Picture
Table Product Specifications of Oligonucleotide Therapeutics
Table Global Oligonucleotide Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Oligonucleotide Therapeutics Revenue Market Share by Types in 2017
Figure Antisense Picture
Figure Ribozymes Picture
Figure Aptamers Picture
Figure miRNA Picture
Figure CpG/Immunostimulatory Picture
Figure RNAi Picture
Figure Others Picture
Table Global Oligonucleotide Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Oligonucleotide Therapeutics Revenue Market Share by Applications in 2017
Figure Infectious Diseases Picture
Figure Oncology Picture
Figure Neurodegenerative Disorders Picture
Figure Cardiovascular Diseases Picture
Figure Kidney Diseases Picture
Figure Others Picture
Table Global Market Oligonucleotide Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oligonucleotide Therapeutics Type and Applications
Table Pfizer Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oligonucleotide Therapeutics Type and Applications
Table Merck Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Oligonucleotide Therapeutics Type and Applications
Table Biogen Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table PCI Biotech Basic Information, Manufacturing Base and Competitors
Table PCI Biotech Oligonucleotide Therapeutics Type and Applications
Table PCI Biotech Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table SomaGenics Basic Information, Manufacturing Base and Competitors
Table SomaGenics Oligonucleotide Therapeutics Type and Applications
Table SomaGenics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table ContraVir Basic Information, Manufacturing Base and Competitors
Table ContraVir Oligonucleotide Therapeutics Type and Applications
Table ContraVir Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Alnylam Basic Information, Manufacturing Base and Competitors
Table Alnylam Oligonucleotide Therapeutics Type and Applications
Table Alnylam Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Regulus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Regulus Therapeutics Oligonucleotide Therapeutics Type and Applications
Table Regulus Therapeutics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ionis Pharmaceuticals Oligonucleotide Therapeutics Type and Applications
Table Ionis Pharmaceuticals Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Oligonucleotide Therapeutics Type and Applications
Table Gilead Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Santaris Pharma Basic Information, Manufacturing Base and Competitors
Table Santaris Pharma Oligonucleotide Therapeutics Type and Applications
Table Santaris Pharma Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oligonucleotide Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue Share by Players (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Share by Players in 2016
Figure Global Oligonucleotide Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Oligonucleotide Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Oligonucleotide Therapeutics Revenue Market Share in 2017
Figure Global Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Market Share by Regions in 2017
Figure North America Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
Table North America Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Oligonucleotide Therapeutics Revenue Market Share by Countries in 2017
Figure USA Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Oligonucleotide Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oligonucleotide Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Oligonucleotide Therapeutics Revenue Market Share by Countries in 2017
Figure China Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Oligonucleotide Therapeutics Revenue by Countries (2013-2018)
Table South America Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Oligonucleotide Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oligonucleotide Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oligonucleotide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oligonucleotide Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Oligonucleotide Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue Share by Type (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Share by Type (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Share by Type in 2017
Table Global Oligonucleotide Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Oligonucleotide Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Antisense Revenue Growth Rate (2013-2018)
Figure Global Ribozymes Revenue Growth Rate (2013-2018)
Figure Global Aptamers Revenue Growth Rate (2013-2018)
Figure Global miRNA Revenue Growth Rate (2013-2018)
Figure Global CpG/Immunostimulatory Revenue Growth Rate (2013-2018)
Figure Global RNAi Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue by Application (2013-2018)
Table Global Oligonucleotide Therapeutics Revenue Share by Application (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Share by Application (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue Share by Application in 2017
Table Global Oligonucleotide Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Oligonucleotide Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Infectious Diseases Revenue Growth Rate (2013-2018)
Figure Global Oncology Revenue Growth Rate (2013-2018)
Figure Global Neurodegenerative Disorders Revenue Growth Rate (2013-2018)
Figure Global Cardiovascular Diseases Revenue Growth Rate (2013-2018)
Figure Global Kidney Diseases Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Oligonucleotide Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Oligonucleotide Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Oligonucleotide Therapeutics Revenue Market Forecast (2018-2023)
  • Global Left Ventricular Assist Device Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Left Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy. Scope of the Report: The global Left Ventricular Assist Device Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast As......
  • Global Magnetic Resonance Imaging (MRI) Transport Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Magnetic Resonance Imaging Transport is a specific apparatus that are manufactured with specific careand special skills, utilized to transport the MRI patients with great care. It is made up of no magneticmaterials as MRI consumes magnetic and radio waves. MRI is useful in detecting various acute diseasesand abnormalities inside the patient's body. Scope of the Report: The worldwide market for Magnetic Resonance Imaging (MRI) Transport is expected to grow at a CAGR of rough......
  • Global MRI Guided Neurosurgical Ablation Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 117
    MRI guided neurosurgical technique which uses MRI guided high intensity laser probe for the ablation of brain cancer cells and destroy the tumor. It is the process in which the patient undergo a surgery where a small hole is drilled in the skull and the probe is directed to the target and kills the target cells by emission of highly focused thermal energy leaving neighboring cells unharmed. Scope of the Report: The global MRI Guided Neurosurgical Ablation market is valued a......
  • Global Examination Nitrile Gloves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Nitrile is the preferred material for disposable gloves in most industries. Scope of the Report: This report focuses on the Examination Nitrile Gloves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Examination Nitrile Gloves is expected to grow at a CAGR of roughly xx% over the next five yea......
  • Global Surgical Nitrile Gloves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Nitrile is the preferred material for disposable gloves in most industries. Scope of the Report: This report focuses on the Surgical Nitrile Gloves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Surgical Nitrile Gloves is expected to grow at a CAGR of roughly xx% over the next five years, wi......
  • Global Reusable Latex and Nitrile Rubber Medical Gloves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Medical gloves are disposable gloves used during medical examinations and procedures to help prevent cross-contamination between caregivers and patients. Scope of the Report: This report focuses on the Reusable Latex and Nitrile Rubber Medical Gloves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide marke......
  • Global Surgical Disposable Medical Gloves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Medical gloves are disposable gloves used during medical examinations and procedures to help prevent cross-contamination between caregivers and patients. Scope of the Report: This report focuses on the Surgical Disposable Medical Gloves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Surgical......
  • Global Disposable Latex and Nitrile Rubber Medical Gloves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Medical gloves are disposable gloves used during medical examinations and procedures to help prevent cross-contamination between caregivers and patients. Scope of the Report: This report focuses on the Disposable Latex and Nitrile Rubber Medical Gloves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide mar......
  • Global Examination Latex and Nitrile Rubber Medical Gloves Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 117
    Medical gloves are disposable gloves used during medical examinations and procedures to help prevent cross-contamination between caregivers and patients. Scope of the Report: This report focuses on the Examination Latex and Nitrile Rubber Medical Gloves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs